StockData
Novo Nordisk A S logo

Novo Nordisk A S (NVO) stock

NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 4/30
$40.70−0.90 (-2.16%)

Close on Nov 17, 2026Market cap $181.73BP/E 12.0Yield –

Novo Nordisk A S EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Novo Nordisk A S's EV/EBITDA was 9.4× on Nov 11, 2026, against 11.0× a year earlier. Over the last 5 years it ranged from 8.3× to 45.3×, with a median of 30.7×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.4×−1.8
2025Dec 31, 202511.2×−14.1
2024Dec 31, 202425.3×−13.4
2023Dec 29, 202338.7×+1.2
2022Dec 30, 202237.6×+5.5
2021Dec 31, 202132.1×+12.8
2020Dec 31, 202019.3×−0.2
2019Dec 31, 201919.5×+4.6
2018Dec 31, 201814.9×−2.1
2017Dec 29, 201717.0×+4.2
2016Dec 30, 201612.9×–

More Novo Nordisk A S figures

See a number that looks wrong?